https://www.selleckchem.com/products/tg003.html
as initially resource-intensive, sending prescribing data directly to providers automated the process without an observed rebound in prescribing. To explore special coagulation characteristics and anticoagulation management in extracorporeal membrane oxygenation (ECMO)-assisted patients with coronavirus disease 2019 (COVID-19). Single-center, retrospective observation of a series of patients. Laboratory-confirmed severe COVID-19 patients who received venovenous ECMO support from January 20-May 20, 2020. This study analyzed the anticoagula
Like
Comment
Share
